ArticleDiabetes, obesity & metabolism2024

Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes.

Jingchuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.